HomeBLRX • NASDAQ
add
BioLine RX Ltd - ADR
Nakaraang pagsara
$0.14
Sakop ng araw
$0.14 - $0.14
Sakop ng taon
$0.14 - $1.52
Market cap
28.10M USD
Average na Volume
7.61M
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
(USD) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Kita | 4.94M | — |
Gastos sa pagpapatakbo | 9.51M | -23.06% |
Net na kita | -5.82M | 63.66% |
Net profit margin | -117.78 | — |
Kita sa bawat share | 0.00 | 100.00% |
EBITDA | -4.55M | 62.53% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(USD) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 29.17M | 12.34% |
Kabuuang asset | 52.74M | -0.21% |
Kabuuang sagutin | 44.24M | 11.37% |
Kabuuang equity | 8.50M | — |
Natitirang share | 1.20B | — |
Presyo para makapag-book | 14.26 | — |
Return on assets | -22.95% | — |
Return on capital | -32.31% | — |
Cash Flow
Net change in cash
(USD) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | -5.82M | 63.66% |
Cash mula sa mga operasyon | -9.82M | 0.77% |
Cash mula sa pag-invest | 10.18M | 148.35% |
Cash mula sa financing | -1.22M | -134.81% |
Net change in cash | -787.00K | 66.89% |
Malayang cash flow | -7.91M | -14.83% |
Tungkol
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Wikipedia
Itinatag
2003
Website
Mga Empleyado
79